NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, January 2nd. Investors of record on Thursday, January 23rd will be given a dividend of $0.50 per share on Monday, February 3rd. This represents a $2.00 annualized dividend and a dividend yield of 2.80%. The ex-dividend date is Wednesday, January 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) posted its quarterly earnings data on Wednesday, February, 12th. The pharmacy operator reported $1.73 EPS for the quarter, beating analysts' consensus estimates of $1.68 by $0.05. The pharmacy operator earned $66.89 billion during the quarter, compared to the consensus estimate of $64.01 billion. CVS Health had a net margin of 2.58% and a return on equity of 14.87%. CVS Health's quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.14 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY20 earnings guidance on Wednesday, February, 12th. The company provided earnings per share guidance of $7.04-7.17 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.15.

26 equities research analysts have issued 12 month price targets for CVS Health's stock. Their forecasts range from $61.00 to $97.00. On average, they expect CVS Health's stock price to reach $78.48 in the next year. This suggests a possible upside of 10.0% from the stock's current price. View Analyst Price Targets for CVS Health.

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 7 hold ratings, 17 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News coverage about CVS stock has trended somewhat negative this week, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CVS Health earned a news impact score of -1.4 on InfoTrie's scale. They also gave headlines about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Verizon Communications (VZ), Johnson & Johnson (JNJ), QUALCOMM (QCOM) and Intel (INTC).

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.29%), FMR LLC (2.17%), Franklin Resources Inc. (1.38%), Bank of New York Mellon Corp (1.11%), Charles Schwab Investment Management Inc. (0.91%) and Barrow Hanley Mewhinney & Strauss LLC (0.84%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, State Street Corp, Franklin Resources Inc., FMR LLC, Marshall Wace North America L.P., Caisse DE Depot ET Placement DU Quebec, FIL Ltd and Boston Partners. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including LSV Asset Management, M&G Investment Management Ltd., PNC Financial Services Group Inc., Lord Abbett & CO. LLC, Amundi Pioneer Asset Management Inc., Coho Partners Ltd., Public Sector Pension Investment Board and First Trust Advisors LP. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $71.37.

CVS Health has a market capitalization of $92.85 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]